Internal Medicine, Pulmonary Disease · Flushing, NY
NPI
1790028025
Since 2013
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4199 Main St Ste 202c
Flushing, NY, 11355
Phone (718) 285-6606
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
1,178 services
Medicare patients, 2024
102
Average age 76
Drug cost, 2024
$2.2M
3,503 prescriptions
Company payments, 2025
$3,065
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chuan Jiang was code 99213 (office e&m - established), 218 times for 53 patients. In total Chuan Jiang billed 1,178 services in 49 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 218 | 53 | $73.18 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 111 | 30 | $14.04 | $1,559 |
| 99423 E&M - Miscellaneous | Office | 63 | 31 | $37.54 | $2,365 |
| 94729 Pulmonary Function Testing | Office | 61 | 48 | $51.87 | $3,164 |
| 94726 Pulmonary Function Testing | Office | 61 | 48 | $51.34 | $3,132 |
| 94060 Pulmonary Function Testing | Office | 60 | 48 | $35.20 | $2,112 |
| 94618 Pulmonary Function Testing | Office | 56 | 44 | $30.30 | $1,697 |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 47 | 40 | $115.76 | $5,441 |
| 76604 Ultrasound - Nonspecific | Office | 44 | 34 | $39.40 | $1,734 |
| 95012 Pulmonary | Office | 29 | 28 | $17.82 | $517 |
| 99215 Office E&M - Established | Office | 25 | 15 | $154.41 | $3,860 |
| 94669 Physical, Occupational, and Speech Therapy | Office | 25 | 15 | $19.41 | $485 |
| 94644 Treatment - Miscellaneous | Office | 22 | 16 | $55.96 | $1,231 |
| 99443 Telephone Services | Office | 22 | 17 | $84.53 | $1,860 |
| 76705 Ultrasound - Abdomen and Pelvis | Office | 20 | 19 | $79.48 | $1,590 |
By year: 2022 $76K for 1,098 services; 2023 $67K for 1,209 services; 2024 $63K for 1,178 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 15 | 13 | $8.40 | $126 |
Medicare prescription drug claims, 2024
In 2024, the drug Chuan Jiang prescribed most often to Medicare patients was Breztri Aerosphere (Budesonide/Glycopyr/Formoterol), with 416 prescriptions and refills. In total Chuan Jiang wrote 3,503 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 416 | 446 | 107 | $278K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 195 | 220 | 77 | $5,720 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 167 | 188 | 48 | $118K |
| Montelukast Sodium Generic | 154 | 198 | 41 | $738 |
| Roflumilast Generic | 128 | 150 | 22 | $11K |
| Airsupra Albuterol Sulfate/Budesonide | 119 | 124 | 25 | $59K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 101 | 103 | 29 | $45K |
| Gabapentin Generic | 83 | 85 | 22 | $696 |
| Zolpidem Tartrate Generic | 77 | 77 | 29 | $536 |
| Ofev Nintedanib Esylate | 71 | 71 | Under 11 | $923K |
| Diclofenac Epolamine Generic | 64 | 76 | 22 | $49K |
| Vascepa Icosapent Ethyl | 62 | 82 | 24 | $29K |
| Jardiance Empagliflozin | 49 | 59 | 16 | $34K |
| Clonazepam Generic | 48 | 48 | 19 | $282 |
| Baclofen Generic | 48 | 50 | 21 | $349 |
Brand drugs: - claims; generic drugs: 1,847 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chuan Jiang $3,065 ($3,065 in general payments such as food, travel and fees) from 22 companies. The largest payer was GlaxoSmithKline, LLC. with $679.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 29 | $679 |
| Lilly USA, LLC LLY | 14 | $371 |
| AstraZeneca Pharmaceuticals LP AZN | 18 | $370 |
| Viatris Specialty LLC | 13 | $271 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $247 |
| Genzyme Corporation SNY | 6 | $157 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $155 |
| Merck Sharp & Dohme LLC MRK | 5 | $106 |
| Phathom Pharmaceuticals, Inc. PHAT | 4 | $95.19 |
| Madrigal Pharmaceuticals MDGL | 4 | $94.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.